SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
Sono International seeks IPO in 2025 with $2.1 billion in corporate value
South Korea’s top resort operator Sono International Co. is seeking an initial public offering of its shares on the Korean market next year, r...
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Enormous market ahead for Hopae, S.Korean DID pioneer
To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...
SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn
South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...
EuBiologics gets WHO certification for cholera vaccine facility
South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...
S.Korea sees record-high foreign visitors after pandemic
South Korea saw a record-high number of foreign tourists post-COVID-19 in the first quarter of 2024. The South Korean Ministry of Culture, Spor...
SK Bioscience exports Sky Cellflu to Thailand
South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...
Number of foreign tourists visiting Korea surpasses 11 million in 2023
The number of foreign tourists visiting Korea last year exceeded 11 million, reaching 63% of the pre-COVID level, with over 1 million arrivals month...
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Korea Post resumes kimchi delivery to US
South Korea's state-run postal service agency Korea Post announced on Monday it resumed Express Mail Service (EMS) for shipping kimchi all over the ...
S.Korea releases winter schedule for weekly int’l flights
South Korea will expand its number of weekly flights this winter to Japan and Southeast Asia, two regions expected to have high demand that season, ...
S.Korean airlines see 12.87 mn int’l passengers in Q3 2023
South Korean airlines’ international passenger traffic in the third quarter reached 85% of that over the same period in 2019, the year befor...
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...
Incheon Airport’s cumulative passengers surpass 800 mn
Incheon International Airport, which opened in 2001, has surpassed a cumulative total of 800 million passengers. Incheon International Airport Corpo...
Live commerce app Grip aims to expand into Japan, US in 2024
Imagine you're using a shopping app. You talk to the seller, ask questions and receive answers in real-time on a livestream video. Now and then, the...
Eastar Jet resumes int'l flights after three and half years
South Korea's low-cost carrier Eastar Jet on Sunday said it resumed international flights for the first time in three and a half years starting with...
LG H&H's The Whoo unveils Cheongidan renewal line in Shanghai
LG H&H Co. announced on Thursday its strategy to focus on the Chinese market by unveiling a renewal version of "Cheongidan," the flagship produc...
Foreign visitors to S.Korea in July surpass 1 mn post-COVID-19
The number of foreign tourists visiting South Korea has exceeded 1 million in a month for the first time since the outbreak of COVID-19. According t...
EuBiologics, GC Biopharma to jointly produce cholera vaccine
South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...
POSCO Int'l marks 1st animal vaccine exports
POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...
SK Bioscience resumes output of flu vaccine after two years
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...
SK Bioscience to export $51 bn flu vaccine to Thailand
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...
SK Bioscience buys 6.5 million Novavax shares for $83.4 million
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Wednesday it has signed a deal to buy 6.5 million shares in US vacc...
